z-logo
open-access-imgOpen Access
Mesenchymal stem cells promote proliferation of endogenous neural stem cells and survival of newborn cells in a rat stroke model
Author(s) -
SeungWan Yoo,
SungSoo Kim,
SooYeol Lee,
Hey-Sun Lee,
Hyunsoo Kim,
YoungDon Lee,
Haeyoung SuhKim
Publication year - 2008
Publication title -
experimental and molecular medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.703
H-Index - 82
eISSN - 2092-6413
pISSN - 1226-3613
DOI - 10.3858/emm.2008.40.4.387
Subject(s) - mesenchymal stem cell , neurogenesis , subventricular zone , neuroblast , neural stem cell , stem cell , stem cell transplantation for articular cartilage repair , biology , transplantation , microbiology and biotechnology , doublecortin , medicine , adult stem cell , immunology , cancer research , pathology , neuroscience , endothelial stem cell , central nervous system , in vitro , biochemistry , dentate gyrus
Mesenchymal stem cells (MSCs) secrete bioactive factors that exert diverse responses in vivo. In the present study, we explored mechanism how MSCs may lead to higher functional recovery in the animal stroke model. Bone marrow-derived MSCs were transplanted into the brain parenchyma 3 days after induction of stroke by occluding middle cerebral artery for 2 h. Stoke induced proliferation of resident neural stem cells in subventricular zone. However, most of new born cells underwent cell death and had a limited impact on functional recovery after stroke. Transplantation of MSCs enhanced proliferation of endogenous neural stem cells while suppressing the cell death of newly generated cells. Thereby, newborn cells migrated toward ischemic territory and differentiated in ischemic boundaries into doublecortin+ neuroblasts at higher rates in animals with MSCs compared to control group. The present study indicates that therapeutic effects of MSCs are at least partly ascribed to dual functions of MSCs by enhancing endogenous neurogenesis and protecting newborn cells from deleterious environment. The results reinforce the prospects of clinical application using MSCs in the treatment of neurological disorders.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom